NCT04786262: A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- State
- Under way
- Phase
- Phase 3
- People
- 57 planned
- Started
- 29 Mar 2021
- Primary completion
- 31 Dec 2027
- Arms
- VX-017
- Results
- None posted
- 8 Mar 2021: Trial registered
- 29 Mar 2021: Trial started